HB2595 EngrossedLRB097 07359 RLC 47468 b

1    AN ACT concerning criminal law.
 
2    Be it enacted by the People of the State of Illinois,
3represented in the General Assembly:
 
4    Section 5. The Illinois Controlled Substances Act is
5amended by changing Section 204 as follows:
 
6    (720 ILCS 570/204)  (from Ch. 56 1/2, par. 1204)
7    Sec. 204. (a) The controlled substances listed in this
8Section are included in Schedule I.
9    (b) Unless specifically excepted or unless listed in
10another schedule, any of the following opiates, including their
11isomers, esters, ethers, salts, and salts of isomers, esters,
12and ethers, whenever the existence of such isomers, esters,
13ethers and salts is possible within the specific chemical
14designation:
15        (1) Acetylmethadol;
16        (1.1) Acetyl-alpha-methylfentanyl
17    (N-[1-(1-methyl-2-phenethyl)-
18    4-piperidinyl]-N-phenylacetamide);
19        (2) Allylprodine;
20        (3) Alphacetylmethadol, except
21    levo-alphacetylmethadol (also known as levo-alpha-
22    acetylmethadol, levomethadyl acetate, or LAAM);
23        (4) Alphameprodine;

 

 

HB2595 Engrossed- 2 -LRB097 07359 RLC 47468 b

1        (5) Alphamethadol;
2        (6) Alpha-methylfentanyl
3    (N-(1-alpha-methyl-beta-phenyl) ethyl-4-piperidyl)
4    propionanilide;  1-(1-methyl-2-phenylethyl)-4-(N-
5    propanilido) piperidine;
6        (6.1) Alpha-methylthiofentanyl
7    (N-[1-methyl-2-(2-thienyl)ethyl-
8    4-piperidinyl]-N-phenylpropanamide);
9        (7) 1-methyl-4-phenyl-4-propionoxypiperidine (MPPP);
10        (7.1) PEPAP
11    (1-(2-phenethyl)-4-phenyl-4-acetoxypiperidine);
12        (8) Benzethidine;
13        (9) Betacetylmethadol;
14        (9.1) Beta-hydroxyfentanyl
15    (N-[1-(2-hydroxy-2-phenethyl)-
16    4-piperidinyl]-N-phenylpropanamide);
17        (10) Betameprodine;
18        (11) Betamethadol;
19        (12) Betaprodine;
20        (13) Clonitazene;
21        (14) Dextromoramide;
22        (15) Diampromide;
23        (16) Diethylthiambutene;
24        (17) Difenoxin;
25        (18) Dimenoxadol;
26        (19) Dimepheptanol;

 

 

HB2595 Engrossed- 3 -LRB097 07359 RLC 47468 b

1        (20) Dimethylthiambutene;
2        (21) Dioxaphetylbutyrate;
3        (22) Dipipanone;
4        (23) Ethylmethylthiambutene;
5        (24) Etonitazene;
6        (25) Etoxeridine;
7        (26) Furethidine;
8        (27) Hydroxpethidine;
9        (28) Ketobemidone;
10        (29) Levomoramide;
11        (30) Levophenacylmorphan;
12        (31) 3-Methylfentanyl
13    (N-[3-methyl-1-(2-phenylethyl)-
14    4-piperidyl]-N-phenylpropanamide);
15        (31.1) 3-Methylthiofentanyl
16    (N-[(3-methyl-1-(2-thienyl)ethyl-
17    4-piperidinyl]-N-phenylpropanamide);
18        (32) Morpheridine;
19        (33) Noracymethadol;
20        (34) Norlevorphanol;
21        (35) Normethadone;
22        (36) Norpipanone;
23        (36.1) Para-fluorofentanyl
24    (N-(4-fluorophenyl)-N-[1-(2-phenethyl)-
25    4-piperidinyl]propanamide);
26        (37) Phenadoxone;

 

 

HB2595 Engrossed- 4 -LRB097 07359 RLC 47468 b

1        (38) Phenampromide;
2        (39) Phenomorphan;
3        (40) Phenoperidine;
4        (41) Piritramide;
5        (42) Proheptazine;
6        (43) Properidine;
7        (44) Propiram;
8        (45) Racemoramide;
9        (45.1) Thiofentanyl
10    (N-phenyl-N-[1-(2-thienyl)ethyl-
11    4-piperidinyl]-propanamide);
12        (46) Tilidine;
13        (47) Trimeperidine;
14        (48) Beta-hydroxy-3-methylfentanyl (other name:
15    N-[1-(2-hydroxy-2-phenethyl)-3-methyl-4-piperidinyl]-
16    N-phenylpropanamide).
17    (c) Unless specifically excepted or unless listed in
18another schedule, any of the following opium derivatives, its
19salts, isomers and salts of isomers, whenever the existence of
20such salts, isomers and salts of isomers is possible within the
21specific chemical designation:
22        (1) Acetorphine;
23        (2) Acetyldihydrocodeine;
24        (3) Benzylmorphine;
25        (4) Codeine methylbromide;
26        (5) Codeine-N-Oxide;

 

 

HB2595 Engrossed- 5 -LRB097 07359 RLC 47468 b

1        (6) Cyprenorphine;
2        (7) Desomorphine;
3        (8) Diacetyldihydromorphine (Dihydroheroin);
4        (9) Dihydromorphine;
5        (10) Drotebanol;
6        (11) Etorphine (except hydrochloride salt);
7        (12) Heroin;
8        (13) Hydromorphinol;
9        (14) Methyldesorphine;
10        (15) Methyldihydromorphine;
11        (16) Morphine methylbromide;
12        (17) Morphine methylsulfonate;
13        (18) Morphine-N-Oxide;
14        (19) Myrophine;
15        (20) Nicocodeine;
16        (21) Nicomorphine;
17        (22) Normorphine;
18        (23) Pholcodine;
19        (24) Thebacon.
20    (d) Unless specifically excepted or unless listed in
21another schedule, any material, compound, mixture, or
22preparation which contains any quantity of the following
23hallucinogenic substances, or which contains any of its salts,
24isomers and salts of isomers, whenever the existence of such
25salts, isomers, and salts of isomers is possible within the
26specific chemical designation (for the purposes of this

 

 

HB2595 Engrossed- 6 -LRB097 07359 RLC 47468 b

1paragraph only, the term "isomer" includes the optical,
2position and geometric isomers):
3        (1) 3,4-methylenedioxyamphetamine
4    (alpha-methyl,3,4-methylenedioxyphenethylamine,
5    methylenedioxyamphetamine, MDA);
6        (1.1) Alpha-ethyltryptamine
7    (some trade or other names: etryptamine;
8    MONASE; alpha-ethyl-1H-indole-3-ethanamine;
9    3-(2-aminobutyl)indole; a-ET; and AET);
10        (2) 3,4-methylenedioxymethamphetamine (MDMA);
11        (2.1) 3,4-methylenedioxy-N-ethylamphetamine
12    (also known as: N-ethyl-alpha-methyl-
13    3,4(methylenedioxy) Phenethylamine, N-ethyl MDA, MDE,
14    and MDEA);
15        (2.2) N-Benzylpiperazine (BZP);
16        (3) 3-methoxy-4,5-methylenedioxyamphetamine, (MMDA);
17        (4) 3,4,5-trimethoxyamphetamine (TMA);
18        (5) (Blank);
19        (6) Diethyltryptamine (DET);
20        (7) Dimethyltryptamine (DMT);
21        (8) 4-methyl-2,5-dimethoxyamphetamine (DOM, STP);
22        (9) Ibogaine  (some trade and other names:
23    7-ethyl-6,6,beta,7,8,9,10,12,13-octahydro-2-methoxy-
24    6,9-methano-5H-pyrido [1',2':1,2] azepino [5,4-b]
25    indole; Tabernanthe iboga);
26        (10) Lysergic acid diethylamide;

 

 

HB2595 Engrossed- 7 -LRB097 07359 RLC 47468 b

1        (10.5) Salvia divinorum (meaning all parts of the plant
2    presently classified botanically as Salvia divinorum,
3    whether growing or not, the seeds thereof, any extract from
4    any part of that plant, and every compound, manufacture,
5    salts, isomers, and salts of isomers whenever the existence
6    of such salts, isomers, and salts of isomers is possible
7    within the specific chemical designation, derivative,
8    mixture, or preparation of that plant, its seeds or
9    extracts);
10        (11) 3,4,5-trimethoxyphenethylamine (Mescaline);
11        (12) Peyote (meaning all parts of the plant presently
12    classified botanically as Lophophora williamsii Lemaire,
13    whether growing or not, the seeds thereof, any extract from
14    any part of that plant, and every compound, manufacture,
15    salts, derivative, mixture, or preparation of that plant,
16    its seeds or extracts);
17        (13) N-ethyl-3-piperidyl benzilate (JB 318);
18        (14) N-methyl-3-piperidyl benzilate;
19        (14.1) N-hydroxy-3,4-methylenedioxyamphetamine
20    (also known as N-hydroxy-alpha-methyl-
21    3,4(methylenedioxy)phenethylamine and N-hydroxy MDA);
22        (15) Parahexyl; some trade or other names:
23    3-hexyl-1-hydroxy-7,8,9,10-tetrahydro-6,6,9-trimethyl-6H-
24    dibenzo (b,d) pyran; Synhexyl;
25        (16) Psilocybin;
26        (17) Psilocyn;

 

 

HB2595 Engrossed- 8 -LRB097 07359 RLC 47468 b

1        (18) Alpha-methyltryptamine (AMT);
2        (19) 2,5-dimethoxyamphetamine
3    (2,5-dimethoxy-alpha-methylphenethylamine; 2,5-DMA);
4        (20) 4-bromo-2,5-dimethoxyamphetamine
5    (4-bromo-2,5-dimethoxy-alpha-methylphenethylamine;
6    4-bromo-2,5-DMA);
7        (20.1) 4-Bromo-2,5 dimethoxyphenethylamine.
8    Some trade or other names: 2-(4-bromo-
9    2,5-dimethoxyphenyl)-1-aminoethane;
10    alpha-desmethyl DOB, 2CB, Nexus;
11        (21) 4-methoxyamphetamine
12    (4-methoxy-alpha-methylphenethylamine;
13    paramethoxyamphetamine; PMA);
14        (22) (Blank);
15        (23) Ethylamine analog of phencyclidine.
16    Some trade or other names:
17    N-ethyl-1-phenylcyclohexylamine,
18    (1-phenylcyclohexyl) ethylamine,
19    N-(1-phenylcyclohexyl) ethylamine, cyclohexamine, PCE;
20        (24) Pyrrolidine analog of phencyclidine. Some trade
21    or other names: 1-(1-phenylcyclohexyl) pyrrolidine, PCPy,
22    PHP;
23        (25) 5-methoxy-3,4-methylenedioxy-amphetamine;
24        (26) 2,5-dimethoxy-4-ethylamphetamine
25    (another name: DOET);
26        (27) 1-[1-(2-thienyl)cyclohexyl] pyrrolidine

 

 

HB2595 Engrossed- 9 -LRB097 07359 RLC 47468 b

1    (another name: TCPy);
2        (28) (Blank);
3        (29) Thiophene analog of phencyclidine (some trade
4    or other names: 1-[1-(2-thienyl)-cyclohexyl]-piperidine;
5    2-thienyl analog of phencyclidine; TPCP; TCP);
6        (30) Bufotenine (some trade or other names:
7    3-(Beta-Dimethylaminoethyl)-5-hydroxyindole;
8    3-(2-dimethylaminoethyl)-5-indolol;
9    5-hydroxy-N,N-dimethyltryptamine;
10    N,N-dimethylserotonin; mappine);
11        (31)  1-Pentyl-3-(1-naphthoyl)indole 
12    Some trade or other names: JWH-018; 
13        (32) 1-Butyl-3-(1-naphthoyl)indole 
14    Some trade or other names: JWH-073; . 
15        (33) Any compound structurally derived from 
16    3-(1-naphthoyl)indole or 1H-indol-3-yl- 
17    (1-naphthyl)methane by substitution at the 
18    nitrogen atom of the indole ring by alkyl, haloalkyl, 
19    alkenyl, cycloalkylmethyl, cycloalkylethyl or 
20    2-(4-morpholinyl)ethyl whether or not further 
21    substituted in the indole ring to any extent, whether 
22    or not substituted in the naphthyl ring to any extent; 
23        (34) Any compound structurally derived from 
24    3-(1-naphthoyl)pyrrole by substitution at the nitrogen 
25    atom of the pyrrole ring by alkyl, haloalkyl, alkenyl, 
26    cycloalkylmethyl, cycloalkylethyl or 2- 

 

 

HB2595 Engrossed- 10 -LRB097 07359 RLC 47468 b

1    (4-morpholinyl)ethyl, whether or not further 
2    substituted in the pyrrole ring to any extent, whether 
3    or not substituted in the naphthyl ring to any extent; 
4        (35) Any compound structurally derived from 
5    1-(1-naphthylmethyl)indene by substitution 
6    at the 3-position of the indene ring by alkyl, haloalkyl, 
7    alkenyl, cycloalkylmethyl, cycloalkylethyl or 2- 
8    (4-morpholinyl)ethyl whether or not further 
9    substituted in the indene ring to any extent, whether 
10    or not substituted in the naphthyl ring to any extent; 
11        (36) Any compound structurally derived from 
12    3-phenylacetylindole by substitution at the 
13    nitrogen atom of the indole ring with alkyl, haloalkyl, 
14    alkenyl, cycloalkylmethyl, cycloalkylethyl or 2- 
15    (4-morpholinyl)ethyl, whether or not further 
16    substituted in the indole ring to any extent, whether 
17    or not substituted in the phenyl ring to any extent; 
18        (37) Any compound structurally derived from 
19    2-(3-hydroxycyclohexyl)phenol by substitution 
20    at the 5-position of the phenolic ring by alkyl, 
21    haloalkyl, alkenyl, cycloalkylmethyl, cycloalkylethyl 
22    or 2-(4-morpholinyl)ethyl, whether or not substituted 
23    in the cyclohexyl ring to any extent. 
24    (e) Unless specifically excepted or unless listed in
25another schedule, any material, compound, mixture, or
26preparation which contains any quantity of the following

 

 

HB2595 Engrossed- 11 -LRB097 07359 RLC 47468 b

1substances having a depressant effect on the central nervous
2system, including its salts, isomers, and salts of isomers
3whenever the existence of such salts, isomers, and salts of
4isomers is possible within the specific chemical designation:
5        (1) mecloqualone;
6        (2) methaqualone; and
7        (3) gamma hydroxybutyric acid.
8    (f) Unless specifically excepted or unless listed in
9another schedule, any material, compound, mixture, or
10preparation which contains any quantity of the following
11substances having a stimulant effect on the central nervous
12system, including its salts, isomers, and salts of isomers:
13        (1) Fenethylline;
14        (2) N-ethylamphetamine;
15        (3) Aminorex (some other names:
16    2-amino-5-phenyl-2-oxazoline; aminoxaphen;
17    4-5-dihydro-5-phenyl-2-oxazolamine) and its
18    salts, optical isomers, and salts of optical isomers;
19        (4) Methcathinone (some other names:
20    2-methylamino-1-phenylpropan-1-one;
21    Ephedrone; 2-(methylamino)-propiophenone;
22    alpha-(methylamino)propiophenone; N-methylcathinone;
23    methycathinone; Monomethylpropion; UR 1431) and its
24    salts, optical isomers, and salts of optical isomers;
25        (5) Cathinone (some trade or other names:
26    2-aminopropiophenone; alpha-aminopropiophenone;

 

 

HB2595 Engrossed- 12 -LRB097 07359 RLC 47468 b

1    2-amino-1-phenyl-propanone; norephedrone);
2        (6) N,N-dimethylamphetamine (also known as:
3    N,N-alpha-trimethyl-benzeneethanamine;
4    N,N-alpha-trimethylphenethylamine);
5        (7) (+ or -) cis-4-methylaminorex  ((+ or -) cis-
6    4,5-dihydro-4-methyl-4-5-phenyl-2-oxazolamine).
7    (g) Temporary listing of substances subject to emergency
8scheduling. Any material, compound, mixture, or preparation
9that contains any quantity of the following substances:
10        (1) N-[1-benzyl-4-piperidyl]-N-phenylpropanamide
11    (benzylfentanyl), its optical isomers, isomers, salts,
12    and salts of isomers;
13        (2) N-[1(2-thienyl)
14   methyl-4-piperidyl]-N-phenylpropanamide (thenylfentanyl),
15   its optical isomers, salts, and salts of isomers.
16(Source: P.A. 95-239, eff. 1-1-08; 95-331, eff. 8-21-07;
1796-347, eff. 1-1-10; 96-1285, eff. 1-1-11.)